REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/05/2025
Voltar para busca
Dado oficial do USPTO
CANNABIXIR
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
40
Atualização mais recente
06/05/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
3, 5
Data de depósito
14/06/2018
Data de registro
05/05/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/05/2020
Última transação
06/05/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
16
Localização do titular
DE
Examinador
BEN, LINDSEY
Unidade examinadora
L80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Oxygen Handel GmbH
Representantes
Bryan H. Opalko Buchanan Ingersoll & Rooney PC
Classificação técnica
Classes Nice
Classe 3Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 3
Bleaching preparations for laundry use; non-medicated soaps; essential oils; non-medicated cosmetics; non-medicated hair lotions; non-medicated dentifrices; non-medicated toiletry preparations; non-medicated make-up; non-medicated soaps and gels; non-medicated bath preparations; non-medicated deodorants and antiperspirants; non-medicated skineye and nail care preparations; non-medicated hair preparations and treatments; essential oils and aromatic extracts; household cleaning preparations; air fragrancing preparations; household fragrances; balmsother than for medical purposes for use on hairskinlips; cosmetics and cosmetic preparations; oils for cosmetic purposes; massage oils; mineral oils for cosmetic purposes; ointments for cosmetic use; non-medicated body mist; cosmetic shower preparations; cosmeticfluid creams; body and facial butters; body and facial oils; facial peel preparations for cosmetic use; cleaning masks for the face; hair and body wash; cosmetic preparations for bath and shower; cosmetic creams and lotions; topical herbal extracts for cosmetic purposes; make-up preparations; beauty balm creams; beauty milk; beauty care cosmetics; cosmetics in the form of creams; beauty serums; none of the aforementioned goods containing cannabinoids
Classe 5
Pharmaceuticals preparations for the treatment of painincluding chronic painneuropathic pain and fibromyalgiamental diseasesincluding anxiety disordersdiseases of the nervesdepressionattention deficit/hyperactivity disorderbipolar disorder and post-traumatic stress disorderdiseases of the central nervous systemincluding multiple sclerosisspinal cord injuryepilepsyAlzheimer's disease and autismneuromuscular diseasesdegenerative diseasesincluding glaucomacancer and insomnia as well as side effectsincluding nauseavomitinglack of appetite and weight loss; medical preparations for the treatment of painincluding chronic painneuropathic pain and fibromyalgiamental diseasesincluding anxiety disordersdiseases of the nervesdepressionattention deficit/hyperactivity disorderbipolar disorder and post-traumatic stress disorderdiseases of the central nervous systemincluding multiple sclerosisspinal cord injuryepilepsyAlzheimer's disease and autismneuromuscular diseasesdegenerative diseasesincluding glaucomacancer and insomnia as well as side effectsincluding nauseavomitinglack of appetite and weight loss; veterinary preparations for rodentscatsdogsguinea pigsrabbitsfor treatment of painincluding chronic painneuropathic pain and fibromyalgiadiseases of the nervesdiseases of the central nervous systemincluding multiple sclerosisspinal cord injuryneuromuscular diseasesdegenerative diseasesincluding glaucomacancer as well as side effectsincluding nauseavomitinglack of appetite and weight loss; sanitary preparations for medical purposes; dietetic food adapted for medical or veterinary use; dietary supplements for humans and animals; cachets for pharmaceutical purposes; medicated dentifrices; disinfectants and antiseptics; air deodorizers and air purifying preparations; medicated and sanitizing soaps and detergents for personal use; diagnostic preparations for medical use and veterinary use; natural remedies for painincluding chronic painneuropathic pain and fibromyalgiamental diseasesincluding anxiety disordersdiseases of the nervesdepressionattention deficit/hyperactivity disorderbipolar disorder and post-traumatic stress disorderdiseases of the central nervous systemincluding multiple sclerosisspinal cord injuryepilepsyAlzheimer's disease and autismneuromuscular diseasesdegenerative diseasesincluding glaucomacancer and insomnia as well as side effectsincluding nauseavomitinglack of appetite and weight loss; medical plasters; analgesics; appetite stimulant preparations; medicines for human purposes used for the treatment of painincluding chronic painneuropathic pain and fibromyalgiamental diseasesincluding anxiety disordersdiseases of the nervesdepressionattention deficit/hyperactivity disorderbipolar disorder and post-traumatic stress disorderdiseases of the central nervous systemincluding multiple sclerosisspinal cord injuryepilepsyAlzheimer's disease and autismneuromuscular diseasesdegenerative diseasesincluding glaucomacancer and insomnia as well as side effectsincluding nauseavomitinglack of appetite and weight loss; autonomic drugs for medical purposes; pharmaceutical preparations acting on the central nervous system; balms for medical purposes; balms for pharmaceutical purposes; sedatives; deodorantsother than for human beings or for animals; deodorizing room sprays; dragees for medicinal purposes; drugs for medical purposes; pharmaceutical preparationselixirs for the treatment of painincluding chronic painneuropathic pain and fibromyalgiamental diseasesincluding anxiety disordersdiseases of the nervesdepressionattention deficit/hyperactivity disorderbipolar disorder and post-traumatic stress disorderdiseases of the central nervous systemincluding multiple sclerosisspinal cord injuryepilepsyAlzheimer's disease and autismneuromuscular diseasesdegenerative diseasesincluding glaucomacancer and insomnia as well as side effectsincluding nauseavomitinglack of appetite and weight loss; anti-inflammatories; preparations for making medicated beverages; extracts of medicinal plants; ground hempseed fiber for use as a dietary supplement; medicated moisturizing body lotion; medicated moisturizing creams; liquid herbal supplements; nutraceuticals for use as a dietary supplement; topical gels for medical and therapeutic usepainincluding chronic painneuropathic pain and fibromyalgiamental diseasesincluding anxiety disordersdiseases of the nervesdepressionattention deficit/hyperactivity disorderbipolar disorder and post-traumatic stress disorderdiseases of the central nervous systemincluding multiple sclerosisspinal cord injuryepilepsyAlzheimer's disease and autismneuromuscular diseasesdegenerative diseasesincluding glaucomacancer and insomnia as well as side effectsincluding nauseavomitinglack of appetite and weight loss; medicinal drinks; skin care preparations for medical use; medicinal herbs in dried or preserved form; extracts of medicinal herbs; homeopathic pharmaceuticals for use in treatment of painincluding chronic painneuropathic pain and fibromyalgiamental diseasesincluding anxiety disordersdiseases of the nervesdepressionattention deficit/hyperactivity disorderbipolar disorder and post-traumatic stress disorderdiseases of the central nervous systemincluding multiple sclerosisspinal cord injuryepilepsyAlzheimer's disease and autismneuromuscular diseasesdegenerative diseasesincluding glaucomacancer and insomnia as well as side effectsincluding nauseavomitinglack of appetite and weight loss; inhalants for medicinal purposes; capsules for medicines; chewing gum for medical purposes; germicides; medicinal herbs; smoking herbs for medical purposes; herbal extracts for medical purposes; herbal extracts for medicinal purposes; herbal beverages for medicinal use; herbal preparations for medical use; herbal teas for medicinal purposes; hempseed for pharmaceutical purposes; hempseed meal for pharmaceutical purposes; liniments; air deodorizing preparations; hemp milk for pharmaceutical purposes; hemp oil for pharmaceutical purposes; medicated shampoos; medicinal sprays; medicinal tea; medicated food supplements for painincluding chronic painneuropathic pain and fibromyalgiamental diseasesincluding anxiety disordersdiseases of the nervesdepressionattention deficit/hyperactivity disorderbipolar disorder and post-traumatic stress disorderdiseases of the central nervous systemincluding multiple sclerosisspinal cord injuryepilepsyAlzheimer's disease and autismneuromuscular diseasesdegenerative diseasesincluding glaucomacancer and insomnia as well as side effectsincluding nauseavomitinglack of appetite and weight loss; hempseed dietary supplements for painincluding chronic painneuropathic pain and fibromyalgiamental diseasesincluding anxiety disordersdiseases of the nervesdepressionattention deficit/hyperactivity disorderbipolar disorder and post-traumatic stress disorderdiseases of the central nervous systemincluding multiple sclerosisspinal cord injuryepilepsyAlzheimer's disease and autismneuromuscular diseasesdegenerative diseasesincluding glaucomacancer and insomnia as well as side effectsincluding nauseavomitinglack of appetite and weight loss; hempseed oil dietary supplements for painincluding chronic painneuropathic pain and fibromyalgiamental diseasesincluding anxiety disordersdiseases of the nervesdepressionattention deficit/hyperactivity disorderbipolar disorder and post-traumatic stress disorderdiseases of the central nervous systemincluding multiple sclerosisspinal cord injuryepilepsyAlzheimer's disease and autismneuromuscular diseasesdegenerative diseasesincluding glaucomacancer and insomnia as well as side effectsincluding nauseavomitinglack of appetite and weight loss; prescription synthetic narcotics; nervines; nutraceutical preparations for therapeutic or medical purposes; medicinal oils; plant and herb extracts for medicinal use; pharmaceutical compositions for painincluding chronic painneuropathic pain and fibromyalgiamental diseasesincluding anxiety disordersdiseases of the nervesdepressionattention deficit/hyperactivity disorderbipolar disorder and post-traumatic stress disorderdiseases of the central nervous systemincluding multiple sclerosisspinal cord injuryepilepsyAlzheimer's disease and autismneuromuscular diseasesdegenerative diseasesincluding glaucomacancer and insomnia as well as side effectsincluding nauseavomitinglack of appetite and weight loss; reagents for medical use; syrups for pharmaceutical purposes; all of the aforementioned goods in particular for the treatment of painincluding chronic painneuropathic pain and fibromyalgiamental diseasesincluding anxiety disordersdiseases of the nervesdepressionattention deficit/hyperactivity disorderbipolar disorder and post-traumatic stress disorderdiseases of the central nervous systemincluding multiple sclerosisspinal cord injuryepilepsyAlzheimer's disease and autismneuromuscular diseasesdegenerative diseasesincluding glaucomacancer and insomnia as well as side effectsincluding nauseavomitinglack of appetite and weight loss; none of the aforementioned goods containing cannabinoids
Publicações
Histórico de despachos e eventos da marca no USPTO.
40 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
24/12/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/10/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/09/2020
FIMP
FINAL DISPOSITION PROCESSED
11/09/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/08/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
05/05/2020
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/04/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/03/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
18/03/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/02/2020
PUBO
PUBLISHED FOR OPPOSITION
18/02/2020
GPNX
NOTIFICATION PROCESSED BY IB
14/02/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/01/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
29/01/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/01/2020
ALIE
ASSIGNED TO LIE
16/01/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/12/2019
RFNT
REFUSAL PROCESSED BY IB
27/07/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
20/06/2019
GNRT
NON-FINAL ACTION E-MAILED
20/06/2019
CNRT
NON-FINAL ACTION WRITTEN
20/06/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/05/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/05/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/05/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/05/2019
RFNP
REFUSAL PROCESSED BY IB
08/12/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
17/11/2018
RFRR
REFUSAL PROCESSED BY MPU
16/11/2018
DOCK
ASSIGNED TO EXAMINER
15/11/2018
MAFR
APPLICATION FILING RECEIPT MAILED
27/10/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
26/10/2018
CNRT
NON-FINAL ACTION WRITTEN
25/10/2018
DOCK
ASSIGNED TO EXAMINER
23/10/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/10/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
18/10/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CANNABIXIR ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.